MoneyWorks4Me

Dr Reddys Laboratories informs about disclosure

16 Oct 2025 Evaluate
Dr Reddys Laboratories has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1270.60
Cipla 1346.95
Lupin 1930.50
Zydus Lifesciences 1130.30
View more..